- Seer Reports First Quarter 2024 Financial Results
- Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions
- Seer to Report First Quarter 2024 Financial Results on May 8, 2024
- Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
- Seer to Participate in the TD Cowen 44th Annual Health Care Conference
- Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery
- Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
- Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference
- Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum
- Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500
More ▼
Key statistics
On Friday, Seer Inc (SEER:NSQ) closed at 2.11, 45.02% above the 52 week low of 1.46 set on Nov 16, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.13 |
---|---|
High | 2.14 |
Low | 2.07 |
Bid | 2.08 |
Offer | 2.13 |
Previous close | 2.12 |
Average volume | 455.25k |
---|---|
Shares outstanding | 64.94m |
Free float | 57.13m |
P/E (TTM) | -- |
Market cap | 137.67m USD |
EPS (TTM) | -1.29 USD |
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
More ▼